Were Drugs Behind Transgender Shooters’ Violence?

The odd pattern in the data

Researchers at the Crime Prevention and Research Center reported that people who identify as transgender were overrepresented in active-shooter incidents. By one count the share in 2024 was many times their share of the population, and using FBI data from 2018 to 2024 the group accounted for about 3.4 times their population share. Those are alarming ratios, even if the raw numbers remain small. The math says something is happening that deserves a clear, sober look.

What past studies actually found

A 2021 study from the Uniformed Services University looked at transgender and gender-diverse adolescents and compared them with peers and siblings. The study found those adolescents were more likely to have a mental-health diagnosis, to use more mental-health services, and to be prescribed more psychotropic medications. Among 963 youth who began gender-affirming pharmaceuticals, the study noted psychotropic prescriptions increased after those medicines started. Those are important findings, but they do not explain why violence occurs in a few tragic cases.

Side effects do exist and they matter

Psychiatric drugs, puberty blockers, and cross-sex hormones all come with known possible side effects. Antidepressants can cause agitation, anxiety, sleep problems, worsening depression, or suicidal thoughts in some people. Puberty blockers and hormone treatments list mood changes, depression, and other mental-health effects. That does not mean the medicines cause violence. It does mean these drugs can change mood and behavior in ways that warrant careful study, especially when several drugs are used together.

We do not have good research on combined treatments

Clinical trials rarely test psychiatric medications together with gender-affirming drugs. Large parts of medicine assume single-drug effects and then monitor patients in the real world. When two families of drugs both alter brain chemistry and metabolism, the lack of formal combined trials leaves a gap. Regulators and doctors are flying blind on interaction effects more often than most people realize. That gap matters for public safety and for the patients who need clear answers.

Public tragedies raise the stakes

Several recent mass shootings involved attackers who were reported to be transgender or gender-diverse. These cases include fatalities at schools and other public places. News reports indicate some of the attackers had histories of mental-health treatment or psychotropic prescriptions. Each of these events is a real tragedy for victims and communities. Careful, respectful study of the medical and social histories in these rare cases could help prevent future loss.

What should be done next

We need independent, transparent research that asks direct questions. How many young people who later seek gender care were already on psychiatric medications? How do psychotropic drugs and gender-affirming medicines interact over months and years? Are there subgroups at higher risk of severe side effects? Federal hearings, registries, and properly designed clinical trials could produce answers. Families and communities deserve evidence, not guesswork, when children and public safety are at stake.

WE’D LOVE TO HEAR YOUR THOUGHTS! PLEASE COMMENT BELOW.